APCS and pulmonary fibrosis: PRM-151 is a recombinant protein of Pentraxin-2, which has shown good efficacy in the treatment of pulmonary fibrosis and is currently undergoing phase III clinical trials in patients with idiopathic pulmonary fibrosis (IPF) [22, 44].